22nd BfR Consumer Protection Forum
“Opportunities and risks of the e-cigarette”

28. – 29. April 2022, Berlin

00
Days
00
Hours
00
Minutes
00
Seconds

22nd BfR Consumer Protection Forum
“Opportunities and risks of the e-cigarette”

E-cigarettes have been marketed as an alternative to tobacco cigarettes for over 10 years. However, the vast majority of the population is critical of e-cigarettes. This was the result of a representative survey commissioned by the BfR in December 2019. The health risks posed by smoking tobacco cigarettes have been proven in numerous studies since the 1960s, and today we know that cigarette smoking is the main cause of avoidable deaths and numerous diseases. The manufacturers of e-cigarettes show that the content of harmful substances in the emis-sions is significantly lower compared to tobacco ciga-rettes. However, the use of e-cigarettes still poses a considerable health risk. Based on previous data, it is at the moment assumed that with optimal device set-tings and liquid formulations, the health risk is lower than with tobacco cigarettes. Nevertheless, long-term data are lacking.

Livestream

Click the button below to load the content of player.castr.com.

load content (livestream)

22. BfR-Forum Verbraucherschutz
„Chancen und Risiken der E-Zigarette“

28. – 29. April 2022, Berlin

00
Tage
00
Stunden
00
Minuten
00
Sekunden

22. BfR-Forum Verbraucherschutz
„Chancen und Risiken der E-Zigarette“

Die E-Zigarette wird seit über 10 Jahren als Alterna-tive zur Tabakzigarette vermarktet. Die große Mehr-heit der Bevölkerung steht der E-Zigarette allerdings kritisch gegenüber. Das ergab eine repräsentative Umfrage, die das BfR hierzu im Dezember 2019 in Auftrag gegeben hat. Die Gesundheitsgefährdung durch das Rauchen von Tabakzigaretten ist seit den 1960er Jahren in zahlreichen Studien belegt worden, und heute wissen wir, dass Zigarettenrauchen die Hauptursache für vermeidbare Todesfälle und zahl-reiche Krankheiten ist. Die Hersteller von E-Zigaretten zeigen auf, dass der Gehalt gesundheitsschädlicher Substanzen in den Emissionen deutlich geringer ist im Vergleich zur Tabakzigarette. Allerdings stellt der Gebrauch von E-Zigaretten weiterhin ein erhebli-ches Gesundheitsrisiko dar. Aufgrund bisheriger Daten geht man davon aus, dass bei optimalen Gerä-teeinstellungen und Flüssigkeitsformulierungen das Gesundheitsrisiko geringer ist als bei Tabakzigaretten. Es fehlen allerdings Langzeitdaten.

Livestream

Click the button below to load the content of player.castr.com.

load content (livestream)

Mediathek

Erleben Sie vergangene Veranstaltungen des BfR in unserer Mediathek nach. 

Play Video

Welcome and introduction (Tanja Schwerdtle)

BfR Vice President Professor Dr Tanja Schwerdtle gave an outlook on the event „Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event: The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…

Play Video

Recent advances in the field (Thomas Hartung)

Professor Dr Thomas Hartung, Johns Hopkins Bloomberg School of Public Health (JHSPH), Balti-more, USA

Event:
„Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event:
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…

Play Video

High-throughput screening (Anton Simeonov)

Dr Anton Simeonov, National Center for Advancing Translational Sciences(NCATS), National Institutes of Health (NIH), Bethesda, USA

Event:
„Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event:
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…

Play Video

NAM-derived data in regulatory environments: Templates, AOPs and ontologies (Clemens Wittwehr)

Dr Clemens Wittwehr, Joint Research Centre (JRC), Ispra, Italy

Event:
„Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event:
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…

Play Video

Transcriptomics (Roland Grafstroem)

Professor Dr Roland Grafstroem, Karolinska Institute, Solna, Sweden

Event:
„Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event:
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…

Play Video

EU-ToxRisk, omics data for read-across (Bob van de Water)

Professor Dr Bob van de Water, Leiden University

Event:
„Challenges in Public Health Protection in the 21stCentury: New Methods, Omics and Novel Concepts in Toxicology“

Context of the event:
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

For more info on past and future events of the BfR, visit: https://www.bfr-akademie.de/english/a…